---
title: Adragos Pharma vs Symbiosis Pharmaceutical Services
slug_a: adragos-pharma
slug_b: symbiosis-pharma
site: cdmo
review_signal_gate: closed
canonical_path: /compare/adragos-pharma/symbiosis-pharma
---

# Adragos Pharma vs Symbiosis Pharmaceutical Services

Side-by-side profile data from each company listing on this directory.

## Adragos Pharma

- Profile: [/companies/adragos-pharma](/companies/adragos-pharma)

Adragos Pharma — Global CDMO headquartered in Munich offering end-to-end development and manufacturing for small molecules and biologics, including sterile/non-sterile liquids, solids, semi-solids, lyophilization, and prefilled syringes across seven facilities in Europe and Japan.

Services: 17. Modalities: 2. Indications: 1. Locations: 8. Certifications: 0. The strongest documented coverage currently appears in services (17).

### Services

- HPAPI Manufacturing (High-Potency)
- Monoclonal Antibody (mAb) Manufacturing
- Sterile Fill-Finish & Aseptic Manufacturing
- Vial Filling
- Prefilled Syringe (PFS) Filling
- Lyophilization (Freeze Drying)
- Oral Solid Dosage Manufacturing
- Topical & Semi-Solid Manufacturing
- Process Development
- Formulation Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- Stability Testing & Storage
- Secondary Packaging & Labeling
- Cold-Chain Storage & Logistics
- CMC Regulatory Submission Support

### Modalities

- Small Molecule
- Biologics (Monoclonal Antibodies)

### Development capabilities

- Analytical method development
- Formulation development
- ICH stability testing

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Liquid Vials
- Lyophilized Vials
- Prefilled Syringes (PFS)
- Oral Solid Dose (OSD)
- Expression: Mammalian
- HPAPI
- DEA licensed

## Symbiosis Pharmaceutical Services

- Profile: [/companies/symbiosis-pharma](/companies/symbiosis-pharma)

Symbiosis Pharmaceutical Services — UK-based fill-finish CDMO offering rapid access to GMP aseptic manufacturing for clinical and commercial injectable drug products across mAbs, ATMPs, ADCs, RNA, peptides, vaccines, and small molecules.

Services: 18. Modalities: 8. Indications: 0. Locations: 1. Certifications: 1. The strongest documented coverage currently appears in services (18).

### Services

- Small Molecule Development & Manufacturing
- Monoclonal Antibody (mAb) Manufacturing
- Recombinant Protein Manufacturing
- ADC (Antibody-Drug Conjugate) Manufacturing
- Viral Vector Manufacturing
- Cell Therapy Manufacturing
- mRNA Manufacturing
- Peptide Manufacturing
- Vaccine Manufacturing
- Sterile Fill-Finish & Aseptic Manufacturing
- Vial Filling
- Lyophilization (Freeze Drying)
- Process Development
- Formulation Development
- CMC Analytical Development
- Quality Control Testing
- Secondary Packaging & Labeling
- Cold-Chain Storage & Logistics

### Modalities

- Small Molecule
- Biologics (Monoclonal Antibodies)
- Antibody-Drug Conjugate (ADC)
- mRNA
- Cell Therapy
- Gene Therapy
- Peptide
- Vaccine

### Development capabilities

- Analytical method development
- Formulation development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Liquid Vials
- Lyophilized Vials